Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy
Open Access
- 13 June 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical and Molecular Allergy
- Vol. 10 (1), 7-5
- https://doi.org/10.1186/1476-7961-10-7
Abstract
Grass pollen is a major cause of respiratory allergy worldwide and contain a number of allergens, some of theme (Phl p 1, Phl p 2, Phl p 5, and Phl 6 from Phleum pratense, and their homologous in other grasses) are known as major allergens. The administration of grass pollen extracts by immunotherapy generally induces an initial rise in specific immunoglobulin E (sIgE) production followed by a progressive decline during the treatment. Some studies reported that immunotherapy is able to induce a de novo sensitisation to allergen component previously unrecognized. We investigated in 30 children (19 males and 11 females, mean age 11.3 years), 19 treated with sublingual immunotherapy (SLIT) by a 5-grass extract and 11 untreated, the sIgE and sIgG4 response to the different allergen components. Significant increases (p < 0.001) were detected for Phl p 1, Phl p 2, Phl p 5, and Phl p 6, while sIgE levels induced in response to Phl p 7 and Phl p 12 were low or absent at baseline and unchanged following SLIT treatment; no new sensitisation was detected. As to IgG4, significant increases were found for Phl p2 and Phl p 5, while the increase for Phl p 12 was not significant. In the control group, no significant increase in sIgE for any single allergen component was found. These findings confirm that the initial phase of SLIT with a grass pollen extract enhances the sIgE synthesis and show that the sIgE response concerns the same allergen components which induce IgE reactivity during natural exposure.Keywords
This publication has 21 references indexed in Scilit:
- Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: Implications for specific immunotherapyJournal of Allergy and Clinical Immunology, 2012
- Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuationAllergy, 2011
- Mechanisms of allergen-specific immunotherapyJournal of Allergy and Clinical Immunology, 2011
- Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescentsPediatric Allergy and Immunology, 2010
- On mechanism of action of sublingual immunotherapy.Pediatric Allergy and Immunology, 2009
- Grass pollen allergensClinical & Experimental Allergy Reviews, 2008
- Antigenic Similarity among Group 1 Allergens from Grasses and Quantitation ELISA Using Monoclonal Antibodies to Phl p 1International Archives of Allergy and Immunology, 2007
- Evaluation of Recombinant and Native Timothy Pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- Specific IgG4 Antibodies Induced by Subcutaneous Immunotherapy with Timothy Pollen Extract in Allergic PatientsInternational Archives of Allergy and Immunology, 2004
- Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System™Allergy, 2002
- Immunologic and cellular changes accompanying the therapy of pollen allergyJCI Insight, 1971